CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
暂无分享,去创建一个
J. Benito | V. Soriano | P. Martínez | S. Lozano | J. González-lahoz | Mariola López | J. González-Lahoz
[1] L. Perrin,et al. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection , 2002, AIDS.
[2] J. Benito,et al. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users , 2000, AIDS.
[3] Felipe García,et al. Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease. , 2000 .
[4] C. Boucher,et al. The Dominant Source of CD4+ and CD8+ T‐Cell Activation in HIV Infection Is Antigenic Stimulation , 2000, Journal of acquired immune deficiency syndromes.
[5] A. Landay,et al. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease , 2000, AIDS.
[6] John L. Sullivan,et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy , 2000, Nature Medicine.
[7] J. Olofsson,et al. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. , 1999, AIDS.
[8] J Witek,et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. , 1999, JAMA.
[9] M. Sinet,et al. Prospective study of CD8+ lymphocyte activation in relation to viral load in HIV-infected patients with > or = 400 CD4+ lymphocytes per microliter. , 1999, AIDS research and human retroviruses.
[10] H. Ullum,et al. Immune function and phenotype before and after highly active antiretroviral therapy. , 1999, Journal of acquired immune deficiency syndromes.
[11] M. Plana,et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. , 1999, AIDS.
[12] D. Cooper,et al. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA. , 1999, AIDS research and human retroviruses.
[13] G. Carcelain,et al. T cell changes after combined nucleoside analogue therapy in HIV primary infection. , 1999, AIDS.
[14] A. Perelson,et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. , 1999, The New England journal of medicine.
[15] C. A. Macken,et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. , 1999, The New England journal of medicine.
[16] J V Giorgi,et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.
[17] Kaufmann,et al. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV‐1 infection correlates with markers of disease severity and changes towards normalization under treatment , 1999, Clinical and experimental immunology.
[18] R. Weber,et al. Highly active antiretroviral therapy during early HIV infection reverses T‐cell activation and maturation abnormalities , 1998 .
[19] C. Boucher,et al. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. , 1998, The Journal of infectious diseases.
[20] R. Detels,et al. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV‐1 infection , 1998, AIDS.
[21] J V Giorgi,et al. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. , 1998, Cytometry.
[22] R. Detels,et al. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[23] P. Girard,et al. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy , 1998, AIDS.
[24] J. Benito,et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[25] C. Sabin,et al. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[26] F. Malavasi,et al. Human CD38, a cell‐surface protein with multiple functions , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] C. Sabin,et al. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. , 1996, AIDS.
[28] C. Franceschi,et al. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. , 1995, The Journal of infectious diseases.
[29] D. Cooper,et al. Effects of primary HIV‐1 infection on subsets of CD4+ and CD8+ T lymphocytes , 1995, AIDS.
[30] H. Prince,et al. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. , 1991, Journal of acquired immune deficiency syndromes.
[31] R. Detels,et al. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.
[32] A. Abbot,et al. The Follicular Dendritic Cell: Long Term Antigen Retention During Immunity , 1980, Immunological reviews.